Australia’s leading vaccine advisory body has recommended Novavax be used as a COVID-19 booster.
The Australian Technical Advisory Group on Immunisation recommended Novavax be used as a booster for those 18 and over where an mRNA vaccine such as Pfizer is not suitable.
Health Minister Greg Hunt said since Novavax was first approved by the country’s medical regulator, more than 25,000 doses of the vaccine have been administered as a first dose.
“The Therapeutic Goods Administration is currently considering an application for whole of population use of the Novavax COVID-19 vaccine as a booster,” Mr Hunt said.
“The TGA and ATAGI continue to review emerging evidence on all COVID-19 vaccines.”
Novavax was the first protein-based COVID vaccine to have been approved in Australia.
The federal government has acquired 51 million doses of Novavax as part of the vaccine rollout.
So far, 11.6 million boosters have been administered.
(Australian Associated Press)